Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08ZFC
|
|||
| Former ID |
DIB003235
|
|||
| Drug Name |
IGN-312
|
|||
| Synonyms |
Glycoengineered IGN-311 derived MAb, Aphton; Glycoengineered IGN-311 derived MAb, Igeneon; Anti-Lewis Y mAb (Potelligent, cancer immunotherapy), Igeneon
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Igeneon GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020633) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.